| 000 | 01219 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250515080419.0 | ||
| 264 | 0 | _c20070925 | |
| 008 | 200709s 0 0 eng d | ||
| 022 | _a1744-7682 | ||
| 024 | 7 |
_a10.1517/14712598.7.8.1257 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMurad, Yanal M | |
| 245 | 0 | 0 |
_aCPG-7909 (PF-3512676, ProMune): toll-like receptor-9 agonist in cancer therapy. _h[electronic resource] |
| 260 |
_bExpert opinion on biological therapy _cAug 2007 |
||
| 300 |
_a1257-66 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xtherapeutic use |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _ximmunology |
| 650 | 0 | 4 |
_aOligodeoxyribonucleotides _xtherapeutic use |
| 650 | 0 | 4 |
_aRandomized Controlled Trials as Topic _xtrends |
| 650 | 0 | 4 |
_aToll-Like Receptor 9 _xagonists |
| 700 | 1 | _aClay, Timothy M | |
| 700 | 1 | _aLyerly, H Kim | |
| 700 | 1 | _aMorse, Michael A | |
| 773 | 0 |
_tExpert opinion on biological therapy _gvol. 7 _gno. 8 _gp. 1257-66 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14712598.7.8.1257 _zAvailable from publisher's website |
| 999 |
_c17228369 _d17228369 |
||